Ottawa Hospital Research Institute: Venous Thrombosis trials

The registry lists 12 Venous Thrombosis studies with Ottawa Hospital Research Institute as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 2 2Phase 3 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)RecruitingNCT07372716Not applicable
• Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous LinesCompletedNCT03506815Phase 3Results posted
• Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)CompletedNCT02297373Results posted
• Venous Thrombosis Virtual Surveillance in COVID-19CompletedNCT04865913
• Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-DimerStatus unknownNCT02507180
• Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary EvaluationTerminatedNCT02066597Phase 2
• Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismCompletedNCT01602445
• Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer PatientsWithdrawnNCT01602432
• Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon CancerCompletedNCT00967148Not applicable
• Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismCompletedNCT00773448Not applicable
• Understanding Risk Factors Involved in Developing a Second Blood Clot.Status unknownNCT00261014
• The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean SectionCompletedNCT00225108Phase 2/3